Your browser doesn't support javascript.
loading
Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma.
Waldschmidt, Johannes M; Kloeber, Jake A; Anand, Praveen; Frede, Julia; Kokkalis, Antonis; Dimitrova, Valeriya; Potdar, Sayalee; Nair, Monica S; Vijaykumar, Tushara; Im, Nam Gyu; Guillaumet-Adkins, Amy; Chopra, Nitish; Stuart, Hannah; Budano, Lillian; Sotudeh, Noori; Guo, Guangwu; Grassberger, Clemens; Yee, Andrew J; Laubach, Jacob P; Richardson, Paul G; Anderson, Kenneth C; Raje, Noopur S; Knoechel, Birgit; Lohr, Jens G.
Affiliation
  • Waldschmidt JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Kloeber JA; Harvard Medical School, Boston, Massachusetts.
  • Anand P; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Frede J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Kokkalis A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Dimitrova V; Harvard Medical School, Boston, Massachusetts.
  • Potdar S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Nair MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Vijaykumar T; Harvard Medical School, Boston, Massachusetts.
  • Im NG; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Guillaumet-Adkins A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Chopra N; Harvard Medical School, Boston, Massachusetts.
  • Stuart H; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Budano L; Harvard Medical School, Boston, Massachusetts.
  • Sotudeh N; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Guo G; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Grassberger C; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Yee AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Laubach JP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Richardson PG; Harvard Medical School, Boston, Massachusetts.
  • Anderson KC; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Raje NS; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Knoechel B; Harvard Medical School, Boston, Massachusetts.
  • Lohr JG; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Clin Cancer Res ; 27(23): 6432-6444, 2021 12 01.
Article in En | MEDLINE | ID: mdl-34518309
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma / Multiple Myeloma Limits: Humans Language: En Journal: Clin Cancer Res Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma / Multiple Myeloma Limits: Humans Language: En Journal: Clin Cancer Res Year: 2021 Document type: Article